Cargando…

Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al.

Detalles Bibliográficos
Autores principales: Leroy, Christophe, Lautrette, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093332/
https://www.ncbi.nlm.nih.gov/pubmed/33939037
http://dx.doi.org/10.1186/s13613-021-00859-9
_version_ 1783687789345243136
author Leroy, Christophe
Lautrette, Alexandre
author_facet Leroy, Christophe
Lautrette, Alexandre
author_sort Leroy, Christophe
collection PubMed
description
format Online
Article
Text
id pubmed-8093332
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-80933322021-05-06 Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al. Leroy, Christophe Lautrette, Alexandre Ann Intensive Care Letter to the Editor Springer International Publishing 2021-05-03 /pmc/articles/PMC8093332/ /pubmed/33939037 http://dx.doi.org/10.1186/s13613-021-00859-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
Leroy, Christophe
Lautrette, Alexandre
Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al.
title Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al.
title_full Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al.
title_fullStr Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al.
title_full_unstemmed Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al.
title_short Response to the letter to the Editor “Regional citrate anticoagulation for intermittent hemodialysis in the intensive care. What is the optimal set-up?” by Gubensek et al.
title_sort response to the letter to the editor “regional citrate anticoagulation for intermittent hemodialysis in the intensive care. what is the optimal set-up?” by gubensek et al.
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093332/
https://www.ncbi.nlm.nih.gov/pubmed/33939037
http://dx.doi.org/10.1186/s13613-021-00859-9
work_keys_str_mv AT leroychristophe responsetothelettertotheeditorregionalcitrateanticoagulationforintermittenthemodialysisintheintensivecarewhatistheoptimalsetupbygubenseketal
AT lautrettealexandre responsetothelettertotheeditorregionalcitrateanticoagulationforintermittenthemodialysisintheintensivecarewhatistheoptimalsetupbygubenseketal